التفاصيل البيبلوغرافية
| العنوان: |
PDE5 Inhibitors Offer Novel Mechanisms in Combination and Solo Cancer Therapy |
| المؤلفون: |
Lyday, Robert W., Etters, Abigail M., Kim, Chris, Magana, Fernando, Pontipiedra, Gabriel M., Singh, Naveen K.M., Kadavakollu, Samuel |
| المصدر: |
Current Cancer Therapy Reviews; August 2017, Vol. 13 Issue: 2 p107-119, 13p |
| مستخلص: |
Background: Phosphodiesterase-5 (PDE5) inhibitors demonstrate off-label anticancer properties, acting through a variety of mechanisms that ultimately reduce tumor proliferation. Method: Combining PDE5 inhibitors with other anti-oncotic agents further enhances their effectiveness against tumors. Mechanistically, PDE5 inhibitors have been shown to inhibit ATP binding cassette (ABC) transporter protein activity, potentiate reactive oxygen species (ROS) activity, decrease FADD-like IL-1β-converting enzyme (FLICE)- inhibitory protein (c-FLIP) expression, increase blood-brain tumor barrier (BTB) permeability, and, when administered as a combination therapy, sensitize tumors to platinum. Conclusion: This review offers insights into the various mechanisms by which PDE5 inhibitors exert their antineoplastic actions. |
| قاعدة البيانات: |
Supplemental Index |
